Q
QuantAbundanciaAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

27,899 signal articles · 193 in last 24h · 135,451 total before filter · latest 2h ago
193last 24h
1100last 7d
177● bullish (7d)
144● bearish (7d)
209publishers
AllMacro305Earnings354M&A79Regulatory24Product11Analyst16
✕ clear all filterssentiment: bearishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
1 Russell 2000 Stock to Consider Right Now and 2 That Underwhelm
StockStory7d agobearish
1 Russell 2000 Stock to Consider Right Now and 2 That Underwhelm

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.

Celsius Holdings (CELH) Stock May Be No Bargain After A 50% Fall And Rich Earnings
Simply Wall St.7d agobearish
Celsius Holdings (CELH) Stock May Be No Bargain After A 50% Fall And Rich Earnings

Celsius Holdings stock has seen a sharp three year decline in shareholder returns, yet the market still prices the company on the rich side compared with its fundamentals. For investors, the question is why a stock with this recent track record continues to screen expensive on broad valuation checks. Over the past three years, Celsius Holdings shares have delivered a total return that is down about 49.5%, which puts recent enthusiasm in a different light. Expectations that the company can...

Apple (AAPL) Cuts Over 200 Jobs Across Siri and Vision Pro Units
Insider Monkey7d agobearish
Apple (AAPL) Cuts Over 200 Jobs Across Siri and Vision Pro Units

On August 21, 2026, Bloomberg reported that Apple Inc. (NASDAQ:AAPL) is eliminating more than 200 positions across its Siri and Vision Pro teams as it redirects resources toward artificial intelligence and new hardware. Roughly 100 roles are being cut from the Vision Pro organization, including largely shutting down its gaming team and shrinking the unit […]

Intuit’s (INTU) Workforce Restructuring Highlights AI Platform Scalability
Insider Monkey7d agobearish
Intuit’s (INTU) Workforce Restructuring Highlights AI Platform Scalability

Rothschild & Co Asset Management, an investment management company, released its “LongRun Equity Strategy” second-quarter 2026 investor letter. The letter can be downloaded here. The fund focuses on acquiring high-quality franchises for the long term, focusing on companies with strong competitive positions and sustainable business models. The strategy increased 7.6% (in EUR, unhedged) in the […]

Investing.com7d agobearish
BioNTech drops 10% on mRNA trial failure, highlighting Moderna contrast

Investing.com -- BioNTech SE (NASDAQ: BNTX) shares tumbled 10% in Friday, rapidly unwinding the gains the stock had accumulated during a sector-wide mRNA rally just days prior. The selloff was triggered by the company’s announcement that it has terminated a Phase 2 trial for its mRNA cancer vaccine in colorectal cancer due to futility—a stark reality check for investors hoping the mRNA oncology revolution would be a rising tide that lifts all boats. The timing of the setback could not be more vi

3 Russell 2000 Stocks We Steer Clear Of
StockStory7d agobearish
3 Russell 2000 Stocks We Steer Clear Of

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.

Investing.com7d agobearish
Alnylam stock drops on rival heart trial: Why analysts see core business safe

Investing.com -- A major clinical trial failure in heart disease is reverberating across Wall Street, wiping hundreds of millions of dollars off the market value of RNA-therapeutics pioneer Alnylam Pharmaceuticals before the opening bell on Friday. Shares of Alnylam (NASDAQ: ALNY) fell nearly 4.9% in pre-market trading following the full presentation of data from a rival drug trial at the European Society of Cardiology Congress in Munich. The detailed results from AstraZeneca and Ionis Pharmaceu

Fed Credibility Is On The Line In Warsh Jackson Hole Speech (Live Coverage)
Investor's Business Daily7d agobearish
Fed Credibility Is On The Line In Warsh Jackson Hole Speech (Live Coverage)

The speech gives Warsha chance make up for his July 29 news conference that sent long-term Treasury yields jumping amid doubts about his determination to rein in inflation. S&P 500 futures are slightly lower and the 10-year Treasury yield modestly higher ahead of the big speech. The developments since July 29 have only raised the stakes for Warsh's talk.

3 Small-Cap Stocks That Fall Short
StockStory7d agobearish
3 Small-Cap Stocks That Fall Short

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.